Pascal Soriot will announce full-year 2012 financial results for AstraZeneca on 31st January. &nbsp, &nbsp, Related news: AstraZeneca's new CEO removes R&amp,D, commercial heads (Reuters ...

Bayer has won a key FDA approval to extend the use of its prostate cancer therapy Nubeqa, as it tries to claim market share from rival drugs and fulfil its aim of building the drug into a €3 ...